Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Peet Nooijen"'
Autor:
Madeleine R. Berendsen, Diede A.G. van Bladel, Eva Hesius, Fleur A. de Groot, Leonie I. Kroeze, Jos Rijntjes, Jeroen A.C.W. Luijks, Brigiet Hoevenaars, Altuna Halilovic, Peet Nooijen, Esther van Bladel, Susan de Jonge-Peeters, Chantal Lensen, Hans Pruijt, Ellen van der Spek, Joost S.P. Vermaat, Corine Hess, Konnie M. Hebeda, Wendy B.C. Stevens, J. Han J.M. van Krieken, Michiel van den Brand, Patricia J.T.A. Groenen, Blanca Scheijen
Publikováno v:
Modern Pathology, 36
Modern Pathology, 36(5). ELSEVIER SCIENCE INC
Modern Pathology, 36, 5
Modern Pathology, 36(5). ELSEVIER SCIENCE INC
Modern Pathology, 36, 5
Approximately one-third of patients with diffuse large B-cell lymphoma (DLBCL) relapse and often require salvage chemotherapy followed by autologous stem cell transplantation. In most cases, the clonal relationship between the first diagnosis and sub
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9db5e019cdc1fa5d0040d95489fd768a
https://hdl.handle.net/2066/291853
https://hdl.handle.net/2066/291853
Autor:
Madeleine Berendsen, Diede van Bladel, Eva Hesius, Fleur de Groot, Leonie Kroeze, Jos Rijntjes, Jeroen Luijks, Brigiet Hoevenaars, Altuna Halilovic, Peet Nooijen, Ellen van der Spek, Joost Vermaat, Corine Hess, Konnie Hebeda, Wendy Stevens, J. Han van Krieken, Michiel van den Brand, Patricia Groenen, Blanca Scheijen
Approximately one-third of diffuse large B-cell lymphoma (DLBCL) patients relapse, who often require salvage chemotherapy followed by autologous stem cell transplantation. In most cases, the clonal relationship between the first diagnosis and subsequ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::31e756be2f8c110ad51de4572bb9e7e5
https://doi.org/10.21203/rs.3.rs-1862007/v1
https://doi.org/10.21203/rs.3.rs-1862007/v1
Autor:
Yuji Yoshida, Brian Freeman, Peter G. Rose, Ewout Schaafsma, Dilip K. Das, Ajita Avinash Pandit, Christine K.C. Loo, Yoshikazu Nishino, Hy Sook Kim, Dick H. Verbeek, Zafar A. Sheikh, Min-Cheol Lee, Chan Choi, Subhash Kumari Gupta, Garth Perkins, Kyung-Soo Kim, Marcel Mravunac, Chang-Soo Park, Sung Ran Hong, Grace C. H. Yang, Kien T. Mai, Atefeh Shahim-ain, Neeta Kumar, Sanjay Kumar Gupta, Mrinmay K. Mallik, Alireza Rasekhi, Michael Rodriguez, Agnes Meersman, Vicki J. Schnadig, Jae-Hun Chung, Shinji Sato, Vaidehi Kannan, Chikako Okamura, Isamu Ito, Fernando Schmitt, Perikala V. Kumar, Annelies Monhemius, Ricardo González-Cámpora, Abdol Rasool Talei, Jerry Waisman, Jae Soo Koh, Soo Yong Lee, Dina R. Mody, Sahed K. Pathan, Deborah Witte, Jong Sook Park, Horace C. Wu, Jasmina Ahluwalia, Nobuhide Masawa, Ken Shimizu, Amit Goel, Kusum Joshi, Luis Cirnes, Ali Shafei, Venetia R. Sarode, Tai-Ju Hwang, Claudia P. Molina, Mary L. Ostrowski, Shyama Jain, Hossein M. Yazdi, Hideo Sasaki, Dorota Stanford, Juliana Papellas, M. Jesús Perez Cacho, Javier Azúa Blanco, Shailendra Gune, Joseph F. Nasuti, Gabor Komaromy-Hiller, Masakatsu Sunagawa, José Luis Carvalho, Seth R. Fleisher, Dilip Gupta, Ibrahim Ramzy, Tilde S. Kline, Bita Geramizadeh, Anthony Thijssen, Usha K. Luthra, Sang-Woo Juhng, Issam M. Francis, Min Young Lee, Anne E. Rader, Luan D. Truong, Rana Al-Abdulghani, Jae Hyuk Lee, Jong-Hee Shin, Javier Azúa Romeo, Jin Haeng Chung, Mayura Dinkar Phulpagar, Maria João Gil da Costa, Akira Yajima, Etsuo Takada, Helena Barroca, Jeong Hoon Lee, Sanjay Jogai, Raquel Seruca, Pushpa Sodhani, Javier Ortego, Peet Nooijen, Prabodh K. Gupta, Jong-Hee Nam, Fadi W. Abdul-Karim, Kimberly J. Absher, Saeed Shaleri, Puja Sakhuja
Publikováno v:
Acta Cytologica. 45:111-114
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7891dfdbd08e45d66e4d43f691338fa5
https://doi.org/10.1159/000327267
https://doi.org/10.1159/000327267
Publikováno v:
Pediatric dermatology. 26(2)
Panniculitis is an uncommon condition in childhood and may prove difficult to diagnose both clinically and histologically. The clinical spectrum is similar to that in adults and has been associated with many primary diseases. Noninfectious causes are
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::370dabe0e93130ba40f270ed37b1ff51
https://pubmed.ncbi.nlm.nih.gov/19419479
https://pubmed.ncbi.nlm.nih.gov/19419479
Autor:
Buffart, Tineke E.1,2 (AUTHOR), van den Oord, Rosanne A. H. M.1,3 (AUTHOR), van den Berg, Adriënne4 (AUTHOR), Hilhorst, Riet4 (AUTHOR), Bastiaensen, Niek4 (AUTHOR), Pruijt, Hans F. M.3 (AUTHOR), van den Brule, Adriaan5 (AUTHOR), Nooijen, Peet6 (AUTHOR), Labots, Mariette1 (AUTHOR), de Goeij-de Haas, Richard R.1 (AUTHOR), Dekker, Henk1 (AUTHOR), Piersma, Sander R.1 (AUTHOR), Pham, Thang V.1 (AUTHOR), van der Leij, Theo4 (AUTHOR), de Wijn, Rik4 (AUTHOR), Ruijtenbeek, Rob4,7 (AUTHOR), Jiménez, Connie R.1 (AUTHOR), Verheul, Henk M. W.1,8 (AUTHOR) Henk.verheul@radboudumc.nl
Publikováno v:
Clinical Proteomics. 2/18/2021, Vol. 18 Issue 1, p1-12. 12p.
Autor:
Krijgsman, Danielle, van Leeuwen, Marinus B., van der Ven, John, Almeida, Vanda, Vlutters, Ruud, Halter, David, Kuppen, Peter J. K., van de Velde, Cornelis J. H., Wimberger-Friedl, Reinhold
Publikováno v:
IEEE Journal of Biomedical & Health Informatics; Feb2021, Vol. 25 Issue 2, p381-392, 12p
Publikováno v:
Hematology Week; 8/21/2023, p1684-1684, 1p
Autor:
Maria Helena Hilhorst, Hans Pruijt, Adriaan J. C. van den Brule, Liesbeth Houkes, Rosanne van den Oord, Rik de Wijn, Peet T. G. A. Nooijen
Publikováno v:
Cancer Research. 74:5511-5511
Background: Regorafenib (BAY 73-4506) is the first small molecule tyrosine kinase inhibitor that has been approved for treatment of advanced CRC. In the Correct trial*, 1% of the participants showed a partial response and 42.8 % had stable disease. K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e104249aef18e5b30ae7d12061bf3faf
https://doi.org/10.1158/1538-7445.am2014-5511
https://doi.org/10.1158/1538-7445.am2014-5511
Publikováno v:
Pediatric Dermatology; Mar/Apr2009, Vol. 26 Issue 2, p222-223, 2p, 2 Charts
Autor:
Hans Pruijt, Peet T. G. A. Nooijen, Monique Mommersteeg, Rosanne van den Oord, Adriaan J. C. van den Brule, Rob Ruijtenbeek, Riet Hilhorst, Rik de Wijn
Publikováno v:
Cancer Research. 73:5586-5586
Background. Due to the biological heterogeneity, response to systemic therapy is variable in colon cancer. Chemotherapy improves median survival from 6-12 months to 18-24 months. Epidermal growth factor receptor (EGFR) antibodies have shown to improv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::80be4a710a73b9e26caf45141e1aaf47
https://doi.org/10.1158/1538-7445.am2013-5586
https://doi.org/10.1158/1538-7445.am2013-5586